Cargando…

Obesity paradox as a new insight from postoperative complications in gastric cancer

The obesity paradox is reported to exist in various diseases. However, obesity is a pivotal issue in gastric cancer (GC) patients because of the surgical difficulty related to postoperative abdominal infectious complications (PAIC). This study clarified the existence of the obesity paradox in GC. Be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kamiya, Hajime, Komatsu, Shuhei, Nishibeppu, Keiji, Ohashi, Takuma, Konishi, Hirotaka, Shiozaki, Atsushi, Kubota, Takeshi, Fujiwara, Hitoshi, Otsuji, Eigo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284837/ https://www.ncbi.nlm.nih.gov/pubmed/37344511 http://dx.doi.org/10.1038/s41598-023-36968-7

Ejemplares similares

Differences of clinical features and outcomes between male and female elderly patients in gastric cancer
por: Arakawa, Hiroshi, et al.
Publicado: (2023)

Evaluating prognostic value and stage migration effects using a positive lymph node ratio in adenocarcinoma of the esophagogastric junction
por: Kamiya, Hajime, et al.
Publicado: (2023)

A shorter distal resection margin is a surrogate marker of nodal metastasis and poor prognosis in distal gastrectomy for advanced gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2023)

Plasma miR‐1254 as a predictive biomarker of chemosensitivity and a target of nucleic acid therapy in esophageal cancer
por: Takashima, Yusuke, et al.
Publicado: (2023)

Clinical impact of postoperative interval until adjuvant chemotherapy following curative gastrectomy for advanced gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2021)

Plasma microRNA profiles: identification of miR-1229-3p as a novel chemoresistant and prognostic biomarker in gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2020)

Venous invasion as a risk factor for recurrence after gastrectomy followed by chemotherapy for stage III gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2018)

Overexpression of Tetraspanin31 contributes to malignant potential and poor outcomes in gastric cancer
por: Takashima, Yusuke, et al.
Publicado: (2022)

TRIM37 contributes to malignant outcomes and CDDP resistance in gastric cancer
por: Nishibeppu, Keiji, et al.
Publicado: (2021)

Low plasma levels of miR-101 are associated with tumor progression in gastric cancer
por: Imamura, Taisuke, et al.
Publicado: (2017)

Significance of a preoperative systemic immune-inflammation index as a predictor of postoperative survival outcomes in gastric cancer
por: Inoue, Hiroyuki, et al.
Publicado: (2021)

Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2017)

Correction: Overexpression of CTEN relates to tumor malignant potential and poor outcomes of adenocarcinoma of the esophagogastric junction
por: Aratani, Kenichi, et al.
Publicado: (2019)

Persistent Postgastrectomy Hypoglycemia Unawareness in Patients With Gastric Cancer Unveiled by a Prospective Study
por: Kubota, Takeshi, et al.
Publicado: (2022)

Anoctamin 5 regulates the cell cycle and affects prognosis in gastric cancer
por: Fukami, Tomoyuki, et al.
Publicado: (2022)

Low levels of tumour suppressor miR-655 in plasma contribute to lymphatic progression and poor outcomes in oesophageal squamous cell carcinoma
por: Kiuchi, Jun, et al.
Publicado: (2019)

Overexpression of PBK/TOPK relates to tumour malignant potential and poor outcome of gastric carcinoma
por: Ohashi, Takuma, et al.
Publicado: (2017)

Circulating circERBB2 as a potential prognostic biomarker for gastric cancer: An investigative study
por: Nanishi, Kenji, et al.
Publicado: (2020)

Prognostic impact of the preoperative hemoglobin A1c levels in patients with gastric cancer surgery depends on postoperative complications
por: Shibamoto, Jun, et al.
Publicado: (2020)

Diagnostic accuracy of the gastric cancer T-category with respect to tumor localization
por: Nanishi, Kenji, et al.
Publicado: (2020)

Liquid biopsy in patients with hepatocellular carcinoma: Circulating tumor cells and cell-free nucleic acids
por: Okajima, Wataru, et al.
Publicado: (2017)

Overexpression of denticleless E3 ubiquitin protein ligase homolog (DTL) is related to poor outcome in gastric carcinoma
por: Kobayashi, Hiroki, et al.
Publicado: (2015)

ANO9 regulates PD‐L2 expression and binding ability to PD‐1 in gastric cancer
por: Katsurahara, Keita, et al.
Publicado: (2021)

Depleted tumor suppressor miR-107 in plasma relates to tumor progression and is a novel therapeutic target in pancreatic cancer
por: Imamura, Taisuke, et al.
Publicado: (2017)

A successful case of a para-aortic lymphocele treated with autologous peripheral blood injection
por: Nishibeppu, Keiji, et al.
Publicado: (2017)

Postoperative liver dysfunction is associated with poor long-term outcomes in patients with colorectal cancer: a retrospective cohort study
por: Sumiyoshi, Shutaro, et al.
Publicado: (2023)

Predictors of the difficulty of transcervical subcarinal lymph node dissection for esophageal cancer
por: Furuke, Hirotaka, et al.
Publicado: (2023)

Plasma microRNA profiles: identification of miR-23a as a novel biomarker for chemoresistance in esophageal squamous cell carcinoma
por: Komatsu, Shuhei, et al.
Publicado: (2016)

Tumor exosome-mediated promotion of adhesion to mesothelial cells in gastric cancer cells
por: Arita, Tomohiro, et al.
Publicado: (2016)

Evaluation of subcarinal lymph node dissection and metastasis in transmediastinal radical esophagectomy
por: Shibamoto, Jun, et al.
Publicado: (2021)

Aquaporin 1 suppresses apoptosis and affects prognosis in esophageal squamous cell carcinoma
por: Yamazato, Yuzo, et al.
Publicado: (2018)

The K–Cl Cotransporter KCC3 as an Independent Prognostic Factor in Human Esophageal Squamous Cell Carcinoma
por: Shiozaki, Atsushi, et al.
Publicado: (2014)

Efficacy of a Hypotonic Treatment for Peritoneal Dissemination from Gastric Cancer Cells: An In Vivo Evaluation
por: Shiozaki, Atsushi, et al.
Publicado: (2014)

Role of Extracellular High-Mobility Group Box-1 as a Therapeutic Target of Gastric Cancer
por: Takaki, Wataru, et al.
Publicado: (2022)

Absolute lymphocyte count and C-reactive protein-albumin ratio can predict prognosis and adverse events in patients with recurrent esophageal cancer treated with nivolumab therapy
por: Inoue, Hiroyuki, et al.
Publicado: (2022)

Chloride intracellular channel 1 as a switch among tumor behaviors in human esophageal squamous cell carcinoma
por: Kobayashi, Toshiyuki, et al.
Publicado: (2018)

The expression and role of TRPV2 in esophageal squamous cell carcinoma
por: Kudou, Michihiro, et al.
Publicado: (2019)

Nutrition update in gastric cancer surgery
por: Kubota, Takeshi, et al.
Publicado: (2020)

Na(+)/H(+) exchanger 1 has tumor suppressive activity and prognostic value in esophageal squamous cell carcinoma
por: Ariyoshi, Yosuke, et al.
Publicado: (2016)

Roles of voltage-gated potassium channels in the maintenance of pancreatic cancer stem cells
por: Shiozaki, Atsushi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7kdoqvs0qqmnosmm576dk00oqc